Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Secerna Shares IP Law Insights With Durham University Students
Industry news, News, Careers 26/11/2024

Secerna Sparks Interest in IP Law at Durham University

EPO 2021
European, Industry news, News 19/11/2024

Unitary Patent: Legal provision to implement EU sanctions against Russia

A to Z: Drugs in Highlight: A is for AKEEGA®
News, A to Z Feature 15/11/2024

A to Z: Drugs in Highlight: A is for AKEEGA®

Sweden Aims to Protect Its Brand with Trademark Application
European, Industry news, News 13/11/2024

Sweden Aims to Protect Its Brand with Trademark Application

Celebrating Chemistry Week 2024: Funding Schemes and Support Options
Industry news, News 07/11/2024

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

JROBERTS - Secerna
Events, News 05/11/2024

Secerna to discuss IP at Manufacturing & Engineering North East (MENE)

The Art And Science Of Fireworks A Celebration In The Sky
Industry news, News 31/10/2024

Patents and Innovations in Fireworks: A Celebration in the Sky

Secerna Website Images 2023 (19)
Industry news, News 29/10/2024

Halloween Patents: How IP Law Governs the Spookiest Holiday of the Year

T251018 – Exceptions To Patentability And Novelty Of Naturally Occurring Substances
Industry news, News 23/10/2024

T2510/18 – Exceptions to Patentability and Novelty of Naturally Occurring Substances

2 3 4 5 6 7 8 9 10 11 12